FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32416711000001105: Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2568661000001112 Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2568671000001119 Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Losartan 25mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP Losartan 25mg tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient Losartan potassium true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Losartan 25mg tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start